ID   MESO-3T
AC   CVCL_RP21
DR   Wikidata; Q54905292
RX   PubMed=26891694;
CC   Characteristics: Exhibits the ability to grow to high passage (>30) (PubMed=26891694).
CC   Doubling time: 197.8 hours (Note=In 2% FCS), 141.6 hours (Note=In 10% FCS) (PubMed=26891694).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
ST   Source(s): PubMed=26891694
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 11,13
ST   D18S51: 13,14
ST   D21S11: 31,33.2
ST   D3S1358: 18
ST   D5S818: 13
ST   D7S820: 10,11
ST   D8S1179: 11,15
ST   FGA: 24
ST   Penta D: 10
ST   Penta E: 7,13
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
RX   PubMed=26891694; DOI=10.1038/cdd.2015.165; PMCID=PMC4946883;
RA   Chernova T., Sun X.-M., Powley I.R., Galavotti S., Grosso S.,
RA   Murphy F.A., Miles G.J., Cresswell L., Antonov A.V., Bennett J.,
RA   Nakas A., Dinsdale D., Cain K., Bushell M., Willis A.E.,
RA   MacFarlane M.;
RT   "Molecular profiling reveals primary mesothelioma cell lines
RT   recapitulate human disease.";
RL   Cell Death Differ. 23:1152-1164(2016).
//